Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis

Kidney International

Volumn 72, Issue 7, 2007, Pages 853-864

  Alcorta, D A ^a   Barnes, D A ^b,e   Dooley, M A ^c   Sullivan, P ^a   Jonas, B ^c   Liu, Y ^d   Lionaki, S ^a   Reddy, C B ^a,f   Chin, H ^a   Dempsey, A A ^b   Jennette, J C ^a   Falk, R J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Xceed Molecular   (Canada)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e NONE   (United States)

^f WELLESLEY COLLEGE   (United States)

Author keywords

Bioinformatics; Gene expression; Glomerulonephritis; Microarray; mRNA; Vasculitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE ACTIVATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MICROARRAY ANALYSIS; MONITORING; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SMALL VESSEL VASCULITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; UNINDEXED SEQUENCE;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; LEUKOCYTES; LUPUS NEPHRITIS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULITIS;

EID: 34648823219     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002371     Document Type: Article

References (36)

1. Baechler EC, Batliwalla FM, Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610-2615.
2. Crow MK, Kirou KA, Wohlgemuth J. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 2003; 36: 481-490.
3. Bennett L, Palucka AK, Arce E et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711-723.
4. Yang JJ, Pendergraft WF, Alcorta DA et al. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody- associated glomerulonephritis. J Am Soc Nephrol 2004; 15: 2103-2114.
5. Palmer C, Diehn M, Alizadeh AA et al. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 2006; 7: 115.
6. Dennis Jr G, Sherman BT, Hosack DA et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
7. Ohno H. Pathogenetic and clinical implications of non-immunoglobulin; BCL6 translocations in B-cell non-Hodgkin's lymphoma. J Clin Exp Hematopathol 2006; 46: 43-53.
8. Casselman BL, Kilgore KS, Miller BF et al. Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. J Lab Clin Med 1995; 126: 495-502.
9. Falk RJ, Terrell RS, Charles LA et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87: 4115-4119.
10. Kettritz R, Jennette JC, Falk RJ. Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 1997; 8: 386-394.
11. Xiao H, Heeringa P, Liu Z et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005; 167: 39-45.
12. Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110: 955-963.
13. Rarok AA, Limburg PC, Kallenberg CG. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 2003; 74: 3-15.
14. Tait JF, Sakata M, McMullen BA et al. Placental anticoagulant proteins: isolation and comparative characterization of four members of the lipocortin family. Biochemistry 1988; 27: 6268-6276.
15. 2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005; 6: 449-461.
16. Ernst JD, Hoye E, Blackwood RA et al. Purification and characterization of an abundant cytosolic protein from human neutrophils that promotes Ca2(+)-dependent aggregation of isolated specific granules. J Clin Invest 1990; 85: 1065-1071.
17. Park JE, Lee DH, Lee JA et al. Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun 2005; 337: 1283-1287.
18. Harashima M, Niimi S, Koyanagi H et al. Change in annexin A3 expression by regulatory factors of hepatocyte growth in primary cultured rat hepatocytes. Biol Pharm Bull 2006; 29: 1339-1343.
19. Niimi S, Harashima M, Gamou M et al. Expression of annexin A3 in primary cultured parenchymal rat hepatocytes and inhibition of DNA synthesis by suppression of annexin A3 expression using RNA interference. Biol Pharm Bull 2005; 28: 424-428.
20. Waddington SN. Arginase in glomerulonephritis. Kidney Int 2002; 61: 876-881.
21. Tang Y, Xu H, Du X et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab 2006; 26: 1089-1102.
22. Satriano J. Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article. Amino Acids 2004; 26: 321-329.
23. Munder M, Mollinedo F, Calafat J et al. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 2005; 105: 2549-2556.
24. Munder M, Schneider H, Luckner C et al. Suppression of T-cell functions by human granulocyte arginase. Blood 2006; 108: 1627-1634.
25. Waddington S, Cook HT, Reaveley D et al. -arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int 1996; 49: 1090-1096.
26. Hesse M, Modolell M, La Flamme AC et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 2001; 167: 6533-6544.
27. Miller LS, O'Connell RM, Gutierrez MA et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 2006; 24: 79-91.
28. Kim ND, Chou RC, Seung E et al. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. J Exp Med 2006; 203: 829-835.
29. Medoff BD, Tager AM, Jackobek R et al. Antibody-antigen interaction in the airway drives early granulocyte recruitment through BLT1. Am J Physiol Lung Cell Mol Physiol 2006; 290: L170-L178.
30. Pettersson A, Sabirsh A, Bristulf J et al. Pro- and anti-inflammatory substances modulate expression of the leukotriene B4 receptor, BLT1, in human monocytes. J Leukoc Biol 2005; 77: 1018-1025.
31. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
32. Hay EM, Bacon PA, Gordon C et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993; 86: 447-458.
33. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87: 671-678.
34. Pendergraft WF, Alcorta DA, Segelmark M et al. ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. Kidney Int 2000; 57: 1981-1990.
35. Zhao MH, Jones SJ, Lockwood CM. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995; 99: 49-56.
36. Eisen MB, Spellman PT, Brown PO et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.